Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112

Benzinga Newsdesk www.benzinga.com Positive 70.1%

Neg 0% Neu 0% Pos 70.1%

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.